2012版易栓症诊断中国专家共识解读

被引：23

作者：

朱铁楠

赵永强

机构：

[1] 中国医学科学院北京协和医院血液科

来源：

临床血液学杂志 | 2013年 / 26卷 / 03期

关键词：

易栓症; 诊断; 共识; 解读;

D O I：

10.13201/j.issn.1004-2806.2013.02.007

中图分类号：

R543 [血管疾病];

学科分类号：

1002 ; 100201 ;

摘要：

<正>近年来,血栓性疾病的危害及其防治的重要性已广为熟知,但对于易栓症的检测,许多临床医师仍存在一定认识上的误区,例如何种人群应进行易栓症的检测、应该选择哪些易栓症检测项目以及在何时进行检测。因此,2012年中华医学会血液学分会血栓与止血学组根据国内外相关研究的结果拟订了专家共识。

引用

页码：156 / 157

页数：2

共 12 条

[1]

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. R Suzuki,J Suzumiya,M Yamaguchi,S Nakamura,J Kameoka,H Kojima,M Abe,T Kinoshita,T Yoshino,K Iwatsuki,Y Kagami,T Tsuzuki,M Kurokawa,K Ito,K Kawa,K Oshimi. Annals of Oncology . 2010

[2]

Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome[J] . A-Reum Han,Hye Ran Lee,Byeong-Bae Park,In Gyu Hwang,Sarah Park,Sang Cheol Lee,Kihyun Kim,Ho Yeong Lim,Young H. Ko,Sun Hee Kim,Won Seog Kim. &nbspAnnals of Hematology . 2007 (7)

[3]

Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, l -asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant[J] . Daichi Inoue,Yuya Nagai,Yoko Takiuchi,Seiji Nagano,Hiroshi Arima,Takaharu Kimura,Sonoko Shimoji,Minako Mori,Katsuhiro Togami,Sumie Tabata,Soshi Yanagita,Akiko Matsushita,Kenichi Nagai,Hayato Maruoka,Yukihiro Imai,Ritsuro Suzuki,Takayuk

[4]

伴噬血细胞综合征的外周T细胞淋巴瘤临床特点及生存分析[J]. 佟红艳,肖峰,张凤娟,刘辉,戴铁颖,孟海涛,钱文斌,麦文渊,金洁. 中华血液学杂志. 2007(10)

[5]

Phase I / II study ofconcurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan clinical oncology group study JCOG0211. Yamaguchi M,Tobinai K,Oguchi M, et al. Journal of Clinical Oncology . 2009

[6]

HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lympho-histiocytosis. Henter JI, Horne A, Arico M, et al. Pediatric Blood and Cancer . 2007

[7]

Treatmentchoice of immunotherapy or further chemotherapy forEpstein-Barr virus-associated hemophagocytic lym-phohistiocytosis. SHIRAISHI A,OHGA S,DOI T,et al. Pediatric Blood and Cancer . 2012

[8]

Successful treatment of extran-odal natural killer/T-cell lymphoma,nasal type,complicated by se-vere hemophagocytic syndrome,with dexamethasone,methotrexate,ifosfamide,L-asparaginase,and etoposide chemotherapy followed byautologous stem cell transplant. Inoue D,Nagai Y,Takiuchi Y,et al. Leukemia and Lymphoma . 2010

[9]

WHO classification of lumours of haematopoietic and lymphoid tissues. Chan JK,Quintanilla-Martine Z,Ferry JA,et al. IARC Press . 2008

[10]

Treatment of Epstein-Barr virus-related hemophagocyticlymphohistiocytosis （EBV-HLH）:Update 2010. Imashuku S. Journal of Pediatric Hematology Oncology . 2011

← 1 2 →